ABG-WTT Global Life Science Capital Partners GP Ltd Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001832108

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedIndustrials TiltHigh Turnover how tags are computed

Q3 2026 · 1 positions · Total reported value $1.90M · Top-10 concentration 100.0% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 50.0% · 0 new · 0 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, ABG-WTT Global Life Science Capital Partners GP Ltd disclosed 1 equity positions with a combined reported value of $1.90M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Industrials Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were RPID ($1.90M). By sector, the heaviest allocations are Industrials 100.0%. Versus the prior quarter, allocation shifted toward Industrials (+62.6pp) and away from Health Care (-62.6pp).

Versus the prior quarter, ABG-WTT Global Life Science Capital Partners GP Ltd opened 0 new positions, trimmed 0 and fully exited 1, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 50% of names.

Of the 1 positions fully exited versus the prior quarter, the largest were CBLL ($5.36M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • CBLL CERIBELL INC · prev qtr: $5.36M

Insider Transactions (Form 4)

Latest ABG-WTT Global Life Science Capital Partners GP Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

ABG-WTT Global Life Science Capital Partners GP Ltd is an SEC-registered 13F filer. As of Q3 2026 it reported 1 US equity positions with a combined value of $1.90M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 1 positions · $1.90M reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: RPID (RAPID MICRO BIOSYSTEMS INC) at 100.0%
  • Average position size: $1.90M

Sector Tilt

  • Industrials 100.0%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund appears to have a strong bullish stance on RAPID MICRO BIOSYSTEMS INC, increasing its weight to 100% (from 37.39%), suggesting concentrated conviction in this industrial stock. No new positions were added, and no reductions were made. 2. Key moves: No additions or reductions were made this quarter (action=Hold for all positions). The weight increase for RAPID MICRO BIOSYSTEMS INC is solely due to price appreciation (+0.0% QoQ shares, but weight rose due to portfolio rebalancing). 3. Portfolio structure: Highly active and concentrated (single holding at 100%), with extreme bias toward industrials (RAPID MICRO BIOSYSTEMS INC). High risk appetite due to lack of diversification. 4. Per-holding one-liner: RAPID MICRO BIOSYSTEMS INC (RPID) – unverified (business not specified, but likely in industrial biosystems). 5. One-sentence style summary: The fund aggressively concentrated its entire portfolio in RAPID MICRO BIOSYSTEMS INC, taking an active, high-risk bet on this industrial stock with no diversification.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 13:14

Sector Allocation

Industrials 100.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.85M $1.90M 100.00%
100.00%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 50% R 100% F1 67% (modelled on 2026-Q2; 1/10 hit)

Historical Backtest (11 quarters)

Avg precision 86% · recall 95% · F1 89% · avg rank error 1.7 · Top-10 turnover 15%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 67% 57% RYZB · MDVLQ · LUNG · RPID CGON · RPID · LUNG
2024-Q2 100% 100% 100% CGON · RPID · LUNG CGON · RPID · LUNG
2024-Q3 100% 100% 100% CGON · RPID · LUNG CGON · RPID · LUNG
2024-Q4 100% 75% 86% CGON · RPID · LUNG CBLL · CGON · RPID · LUNG
2025-Q1 100% 100% 100% CBLL · CGON · RPID · LUNG CBLL · CGON · RPID · LUNG
2025-Q2 50% 100% 67% CBLL · CGON · RPID · LUNG CBLL · RPID
2025-Q3 100% 100% 100% CBLL · RPID CBLL · RPID
2025-Q4 100% 100% 100% CBLL · RPID CBLL · RPID
2026-Q1 100% 100% 100% CBLL · RPID CBLL · RPID
2026-Q2 100% 100% 100% CBLL · RPID CBLL · RPID
2026-Q3 ★ 50% 100% 67% CBLL · RPID RPID

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did ABG-WTT Global Life Science Capital Partners GP Ltd buy in 2026-Q3?

In its 2026-Q3 13F filing, ABG-WTT Global Life Science Capital Partners GP Ltd reported 1 equity positions worth $1.90M in aggregate; its largest disclosed positions were RPID ($1.90M).

How large is ABG-WTT Global Life Science Capital Partners GP Ltd's portfolio?

ABG-WTT Global Life Science Capital Partners GP Ltd reported $1.90M of long equity holdings across 1 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.

What is ABG-WTT Global Life Science Capital Partners GP Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Industrials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/abg-wtt-global-life-science-capital-partners-gp/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →